INGN icon

Inogen

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 38.5%
Negative

Neutral
Business Wire
3 days ago
Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026.
Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025
Positive
Zacks Investment Research
7 days ago
INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite
Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.
INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite
Neutral
Business Wire
8 days ago
Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States.
Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States
Positive
Zacks Investment Research
13 days ago
Here's Why You Should Add Inogen Stock to Your Portfolio Now
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Positive
Zacks Investment Research
27 days ago
3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD
AVAH, INGN & CCLD show how home care, portable oxygen tech and cloud healthcare IT are reshaping care delivery and efficiency into 2026.
3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD
Positive
Zacks Investment Research
1 month ago
Here's Why You Should Add Inogen Stock to Your Portfolio Now
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Positive
Zacks Investment Research
2 months ago
Down 19.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Inogen (INGN)
Inogen (INGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Down 19.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Inogen (INGN)
Positive
Seeking Alpha
2 months ago
Slow Progress At Inogen
Inogen (INGN) continues its turnaround, showing progress in revenue growth and margins, but the pace remains slower and riskier than the market desires. INGN posted positive adjusted EBITDA and raised full-year guidance, despite mixed quarterly results and ongoing volatility in direct-to-consumer and rental segments. The company's strong market position, new product launches, and partnerships offer long-term growth potential, especially as patients consistently prefer portable solutions.
Slow Progress At Inogen
Negative
Zacks Investment Research
2 months ago
Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y
INGN stock slid despite a narrower Q3 loss and rising B2B demand, as weaker consumer and rental sales weighed on results.
Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y
Neutral
Seeking Alpha
2 months ago
Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript
Inogen, Inc. ( INGN ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Lorna Williams Kevin Smith - President, CEO & Director Michael Bourque - Executive VP, CFO & Corporate Treasurer Conference Call Participants Joseph Conway - Needham & Company, LLC, Research Division Anderson Schock - B. Riley Securities, Inc., Research Division Presentation Operator Welcome to Inogen's Third Quarter 2025 Earnings Conference Call.
Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript